National Gypsum Contributes $27,500 to Enhance Creteau Technology Center Programs
December 24, 2025 - 11:27
The R.W. Creteau Technology Center is excited to share that a significant donation of $27,500 has been made by National Gypsum’s Gold Bond Building facility located in Portsmouth, NH. This generous contribution is aimed at bolstering the Center’s Engineering, Precision Machining, and Advanced Manufacturing programs.
National Gypsum has a longstanding commitment to supporting local initiatives that foster educational opportunities for students, particularly in the fields of Science, Technology, Engineering, and Mathematics (STEM). By investing in these programs, the company is not only enhancing the educational landscape but also helping to prepare the next generation of skilled professionals.
The donation will play a crucial role in providing students with the necessary resources and tools to excel in their studies and future careers. The R.W. Creteau Technology Center appreciates National Gypsum's commitment to community engagement and looks forward to the positive impact this funding will have on its students and programs.
MORE NEWS
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...